We are live on ! Find out more
LA

Linden Advisors Portfolio holdings

AUM $17.9B
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+1.72%
3 Year Est. Return
+2.79%
5 Year Est. Return
+3.4%
10 Year Est. Return
+25.58%
AUM
$9.75B
AUM Growth
+$222M
Cap. Flow
-$8.43B
Cap. Flow %
-86.43%
Top 10 Hldgs %
23.4%
Holding
421
New
14
Increased
Reduced
1
Closed
47
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SZZLW
76
DELISTED
Sizzle Acquisition Corp. Warrant
SZZLW
$51K ﹤0.01%
299,999
BYNOW
77
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$48K ﹤0.01%
349,999
MNTN.WS
78
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$47.6K ﹤0.01%
199,999
ALCYW
79
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$45.6K ﹤0.01%
249,999
VHAQ.WS
80
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$45.3K ﹤0.01%
1,850,000
CLINW
81
DELISTED
Clean Earth Acquisitions Corp. Warrant
CLINW
$45.1K ﹤0.01%
750,000
ASBPW
82
Aspire Biopharma Warrant
ASBPW
$579K
$44.6K ﹤0.01%
899,999
SOAR.WS
83
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$43.1K ﹤0.01%
349,999
SVIIW
84
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$39.1K ﹤0.01%
299,999
FICVW
85
DELISTED
Frontier Investment Corp Warrants
FICVW
$38.1K ﹤0.01%
333,332
PLAOW
86
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$37.6K ﹤0.01%
500,000
ABPWW
87
DELISTED
Abpro Holdings Warrant
ABPWW
$37.5K ﹤0.01%
499,999
ISRLW
88
DELISTED
Israel Acquisitions Corp Warrant
ISRLW
$36.3K ﹤0.01%
250,000
BNZIW icon
89
Banzai International Warrant
BNZIW
$131K
$35.5K ﹤0.01%
335,465
BIOSW
90
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$34.9K ﹤0.01%
500,000
ENERR
91
DELISTED
Accretion Acquisition Corp Right
ENERR
$34.7K ﹤0.01%
400,000
PEGRW
92
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$34.7K ﹤0.01%
367,855
NETC.WS
93
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$34K ﹤0.01%
199,999
MCAAW
94
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$33.9K ﹤0.01%
224,999
RMGCW
95
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$32.8K ﹤0.01%
234,251
CLRCR
96
DELISTED
ClimateRock Right
CLRCR
$31.5K ﹤0.01%
300,000
TVGNW icon
97
Tevogen Bio Warrant
TVGNW
$9.64M
$31.3K ﹤0.01%
649,999
BLEUR
98
DELISTED
bleuacacia ltd Rights
BLEUR
$28.5K ﹤0.01%
600,000
MLECW icon
99
Moolec Science SA Warrant
MLECW
$220K
$27.8K ﹤0.01%
594,637
FIACW
100
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$26.6K ﹤0.01%
286,049

Similar funds

Linden Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Linden Advisors held 421 positions worth $9.75B, up 2.3% from $9.53B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Linden Advisors withdrew a net $8.43B in Q3 2023, closing 47 positions and reducing 1 holding. Its most notable exit was SilverSPAC Inc. Class A Ordinary Share, an estimated $11.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 1.2% of assets, down from 2.3% a quarter earlier, followed by Technology and Materials.

Against the trend, Linden Advisors opened a new position in Seagate worth $26.6M.

  • Linden Advisors's largest Q3 2023 buy was Seagate: 403,193 shares worth $26.6M.
  • Linden Advisors's biggest Q3 2023 reduction was Longevity Health Holdings, Inc. Common Stock, cutting an estimated $3.89M.
  • Linden Advisors fully exited SilverSPAC Inc. Class A Ordinary Share in Q3 2023, selling an estimated $11.8M.
  • Linden Advisors's ten largest holdings make up 23% of its $9.75B portfolio in Q3 2023.
  • Linden Advisors opened 14 new positions and closed 47 in Q3 2023.
  • Linden Advisors's portfolio value rose 2.3% quarter-over-quarter to $9.75B.

Based on Linden Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.